Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fenoprofen calcium hydrate (Progesic dihydrate) 是一非甾体类抗炎症化合物。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 g | ¥ 379 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 312 | 现货 |
产品描述 | Fenoprofen calcium hydrate (Progesic dihydrate) is a non-steroidal anti-inflammatory drug (NSAID). |
体外活性 | Fenoprofen is a more potent inhibitor of collagen-induced platelet aggregation than either aspirin or phenylbutazone. [1] Fenoprofen inhibits the formation of palmitoyl-CoA in both microsomal and peroxisomal fractions, and inhibits the beta-oxidation of lignoceric acid and cerotic acid in rat hepatocytes. [5] Fenoprofen exhibits modest antiproliferative activity against HT-29, DID-1, and SW480 cells with IC50 of 240 μM, 300 μM, and 360 μM, respectively. [6] Fenoprofen (0.1 mM) is an efficient activator of peroxisome proliferator-activated receptor gamma (PPARγ), activating the receptor to a degree comparable to that obtained with the PPARγ ligands BRL49653 and 15-deoxy-D12,14-PGJ2 and the peroxisome proliferator Wy14643. Fenoprofen is also an efficacious activator of PPARα, activating the receptor to a degree comparable to that obtained with the strong peroxisome proliferator Wy14643. Consistently, Fenoprofen treatment promotes lipogenesis in C3H10T1/2 cells. [7] Although Fenoprofen displays only modest antiproliferative activity, Fenoprofen amides can potently induce cell cycle arrest at the G1 phase, as well as apoptosis, probably because of a greater lipophilicity and/or better cell uptake. [9] |
体内活性 | Oral administration of Fenoprofen at 50 mg/kg potently inhibits thrombus formation by 47%, whereas a dose of 200 mg/kg of aspirin is required to reduce thrombus formation 21 %. [1] Similar to indomethacin, adminstration of Fenoprofen inhibits prostaglandin synthesis. [2] In rats with type II collagen-induced arthritis, Fenoprofen treatment at 40 mg/kg/day partially suppresses the paw swelling, but has no significant effect on humoral and cellular responses. [3] Administration of Fenoprofen depresses the rebound contraction, thus transforming the brisk relaxant response, elicited by vagal stimulation or ATP, into long-lasting relaxation. [4] Administration of Fenoprofen causes a strong and dose-related induction of peroxisomal palmitoyl-CoA oxidase, and of carnitine acyltransferase and acyl-CoA hydrolase activities in liver homogenates of mice fed diets. Hepatic catalase activity is significantly increased in mice fed the diet with 0.05 and 0.1% fenoprofen but not the 1% fenoprofen-containing diet. [8] |
细胞实验 | Cells are exposed to various concentrations of Fenoprofen for 6 days. Cell number is determined using the SRB colonimetnic protein stain assay. After 6 days of culture, cells are fixed by the addition of cold trichloroacetic acid to a final concentration of 10%. Plates are incubated at 4 °C for 1 hour, then the supernatant is aspirated and the plates are washed with deionized water. SRB solution is formulated to 0.4% w/v in 1% acetic acid; 100 μL is added to each well and the plates are incubated for 10 minutes at room temperature. Unbound SRB is removed by washing with 1% acetic acid followed by air drying. Bound stain is solubilized with 50 mM unbuffered Tris and absorbance is read by an automated spectrophotometer at a single wavelength of 540 nm.(Only for Reference) |
别名 | Feprona dihydrate, Fenoprofen calcium salt dihydrate, Progesic dihydrate, 非诺洛芬钙二水合物 |
分子量 | 558.63 |
分子式 | C15H14O3·1/2Ca·H2O |
CAS No. | 71720-56-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 15 mg/mL (19.1 mM)
DMSO: 45 mg/mL (57.3 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
Ethanol / DMSO | 1 mM | 1.7901 mL | 8.9505 mL | 17.9009 mL | 44.7523 mL |
5 mM | 0.358 mL | 1.7901 mL | 3.5802 mL | 8.9505 mL | |
10 mM | 0.179 mL | 0.895 mL | 1.7901 mL | 4.4752 mL | |
DMSO | 20 mM | 0.0895 mL | 0.4475 mL | 0.895 mL | 2.2376 mL |
50 mM | 0.0358 mL | 0.179 mL | 0.358 mL | 0.895 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Fenoprofen calcium hydrate 71720-56-4 Apoptosis Immunology/Inflammation Neuroscience Others COX Feprona Dihydrate Feprona dihydrate Cyclooxygenase Fenoprofen calcium salt dihydrate inhibit Fenoprofen calcium Hydrate Progesic dihydrate Progesic Dihydrate 53746-45-5 Fenoprofen Calcium Inhibitor Progesic Fenoprofen calcium 非诺洛芬钙二水合物 Feprona Fenoprofen calcium Dihydrate inhibitor